Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity
Anti-tuberculosis drug-induced hepatitis (ATD- induced hepatitis) has been linked to polymorphisms in genes encoding drug metabolizing enzymes. N-acetyltransferase 2 (NAT2), cytochrome P450 2E1 (CYP2E1) and glutathione S-transferase (loci GSTM1 and GSTT1) are involved in the metabolism of isoniazid,...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Ciências
2014-06-01
|
Series: | Anais da Academia Brasileira de Ciências |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652014000200855&lng=en&tlng=en |
id |
doaj-acde2928298840aaab8d3799b64137f4 |
---|---|
record_format |
Article |
spelling |
doaj-acde2928298840aaab8d3799b64137f42020-11-24T23:23:01ZengAcademia Brasileira de CiênciasAnais da Academia Brasileira de Ciências1678-26902014-06-0186285586510.1590/0001-3765201420130350S0001-37652014000200855Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicityTAIS C. BRITOLIA G. POSSUELOANDREIA R.M. VALIMPÂMELA F. TODENDIANDREZZA W. RIBEIROTATIANA S. GREGIANINICARLA A. JARCZEWSKIMARA H. HUTZMARIA LUCIA R. ROSSETTIARNALDO ZAHAAnti-tuberculosis drug-induced hepatitis (ATD- induced hepatitis) has been linked to polymorphisms in genes encoding drug metabolizing enzymes. N-acetyltransferase 2 (NAT2), cytochrome P450 2E1 (CYP2E1) and glutathione S-transferase (loci GSTM1 and GSTT1) are involved in the metabolism of isoniazid, the most toxic drug for the treatment of tuberculosis (TB). This study was designed to determine the frequency and to evaluate whether polymorphisms at CYP2E1, GSTM1 and GSTT1 genes are associated with drug response, as well as to identify clinical risk factors for ATD-induced hepatitis. A total of 245 Brazilian patients undergoing treatment for TB were genotyped using polymerase chain reaction and restriction fragment length polymorphism and sequencing methods. The frequencies of the CYP2E1 polymorphic alleles RsaI, PstI and DraI are 8%, 8.5% and 12%, respectively. GSTM1 and GSTT1 genes are deleted in 42.9% and 12.4% of the population, respectively. Fifteen patients (6.1%) developed hepatotoxicity. Clinical (HIV, female sex and extrapulmonary TB) and genetic characteristics (CYP2E1 without any mutations, having NAT2 slow acetylator profile) are at higher risk of developing ATD-induced hepatitis in this population. Genotyping for GSTM1 and GSTT1 showed no influence on drug response.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652014000200855&lng=en&tlng=enHepatotoxicidadeisoniazidapolimorfismostuberculose |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
TAIS C. BRITO LIA G. POSSUELO ANDREIA R.M. VALIM PÂMELA F. TODENDI ANDREZZA W. RIBEIRO TATIANA S. GREGIANINI CARLA A. JARCZEWSKI MARA H. HUTZ MARIA LUCIA R. ROSSETTI ARNALDO ZAHA |
spellingShingle |
TAIS C. BRITO LIA G. POSSUELO ANDREIA R.M. VALIM PÂMELA F. TODENDI ANDREZZA W. RIBEIRO TATIANA S. GREGIANINI CARLA A. JARCZEWSKI MARA H. HUTZ MARIA LUCIA R. ROSSETTI ARNALDO ZAHA Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity Anais da Academia Brasileira de Ciências Hepatotoxicidade isoniazida polimorfismos tuberculose |
author_facet |
TAIS C. BRITO LIA G. POSSUELO ANDREIA R.M. VALIM PÂMELA F. TODENDI ANDREZZA W. RIBEIRO TATIANA S. GREGIANINI CARLA A. JARCZEWSKI MARA H. HUTZ MARIA LUCIA R. ROSSETTI ARNALDO ZAHA |
author_sort |
TAIS C. BRITO |
title |
Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity |
title_short |
Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity |
title_full |
Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity |
title_fullStr |
Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity |
title_full_unstemmed |
Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity |
title_sort |
polymorphisms in cyp2e1, gstm1 and gstt1 and anti-tuberculosis drug-induced hepatotoxicity |
publisher |
Academia Brasileira de Ciências |
series |
Anais da Academia Brasileira de Ciências |
issn |
1678-2690 |
publishDate |
2014-06-01 |
description |
Anti-tuberculosis drug-induced hepatitis (ATD- induced hepatitis) has been linked to polymorphisms in genes encoding drug metabolizing enzymes. N-acetyltransferase 2 (NAT2), cytochrome P450 2E1 (CYP2E1) and glutathione S-transferase (loci GSTM1 and GSTT1) are involved in the metabolism of isoniazid, the most toxic drug for the treatment of tuberculosis (TB). This study was designed to determine the frequency and to evaluate whether polymorphisms at CYP2E1, GSTM1 and GSTT1 genes are associated with drug response, as well as to identify clinical risk factors for ATD-induced hepatitis. A total of 245 Brazilian patients undergoing treatment for TB were genotyped using polymerase chain reaction and restriction fragment length polymorphism and sequencing methods. The frequencies of the CYP2E1 polymorphic alleles RsaI, PstI and DraI are 8%, 8.5% and 12%, respectively. GSTM1 and GSTT1 genes are deleted in 42.9% and 12.4% of the population, respectively. Fifteen patients (6.1%) developed hepatotoxicity. Clinical (HIV, female sex and extrapulmonary TB) and genetic characteristics (CYP2E1 without any mutations, having NAT2 slow acetylator profile) are at higher risk of developing ATD-induced hepatitis in this population. Genotyping for GSTM1 and GSTT1 showed no influence on drug response. |
topic |
Hepatotoxicidade isoniazida polimorfismos tuberculose |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652014000200855&lng=en&tlng=en |
work_keys_str_mv |
AT taiscbrito polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity AT liagpossuelo polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity AT andreiarmvalim polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity AT pamelaftodendi polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity AT andrezzawribeiro polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity AT tatianasgregianini polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity AT carlaajarczewski polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity AT marahhutz polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity AT marialuciarrossetti polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity AT arnaldozaha polymorphismsincyp2e1gstm1andgstt1andantituberculosisdruginducedhepatotoxicity |
_version_ |
1725565853832839168 |